Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
aggregate, anniversary, asset, blood, Bulletin, carrying, corroborated, deconsolidated, deferral, demand, Deutsche, diagnosed, directly, distinguish, exit, expansion, FAS, framework, full, Hansenula, Helix, hierarchy, identical, IND, indirectly, individual, inflamed, monitored, Novated, onset, orderly, parent, permitted, Pfizer, preliminarily, proceed, protocol, quoted, ratably, reincorporated, resolution, Restated, revert, SAE, satisfactory, spanning, submitted, thousand, toAmb, uncommon, understand, undertaken, unexercised, unobservable, Wegener, yeast
Removed:
Amb, approach, Argentina, Biotech, bulk, called, chemotherapeutic, Coley, conservative, conventional, DARTT, demonstrated, designated, direct, distinct, division, dosage, dose, ending, endpoint, escalation, Euro, evaluate, follicular, formulated, forward, funded, GlaxoSmithKline, GmbH, granting, Green, histologically, ii, iii, immunogenicity, immunotherapy, improve, infection, Institute, June, launched, low, lymphoma, managed, maximizing, minimal, mouse, multifaceted, NHL, offsetting, onForm, partner, path, pharmacological, policy, preliminary, primate, professional, profit, progression, record, recouped, relapsed, rituximab, schedule, season, selling, showed, Singapore, site, structuring, superiority, SUPERVAX, tested, threshold, toxicity, tumor, wide
Filing tables
Filing exhibits
Related press release
DVAX similar filings
Filing view
External links